Advertisement
Advertisement

PRLD

PRLD logo

Prelude Therapeutics Incorporated

2.03
USD
Sponsored
+0.18
+9.68%
Feb 02, 16:00 UTC -5
Closed
exchange

Pre-Market

2.02

-0.01
-0.44%

Prelude Therapeutics Incorporated Financial Snapshot

Market Cap
127.05M
Beta
0.88
Earnings Per Share (EPS)
-1.47
Price-to-Book (P/B) Ratio
1.79
Operating Margin
--
Total Debt/Equity (D/E)
0.00%
P/E Ratio
--
Return on Equity (ROE)
-121.16%
Current Ratio
3.21%
Free Cash Flow
-79.49M

Earnings Chart

Advertisement